NERV - Minerva Neurosciences, Inc.

QQQ $ 435.98 $ 8.58 (2.01 %)

DIA $ 386.87 $ 4.54 (1.19 %)

SPY $ 511.25 $ 6.26 (1.24 %)

TLT $ 89.88 $ 0.90 (1.01 %)

GLD $ 212.97 $ -0.17 (-0.08 %)

Previous Close

$ 2.37

Open

$ 2.40

Bid

$ 0.00 x 0

Ask

$ 0.00 x 0

Day's Range

$ 2.40 - $ 2.40

52 Week Range

$ 2.29 - $ 13.49

Volume

15,458

Average Volume

Market Cap

17.94M

Beta (5Y Monthly)

$ 0.70

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	05-01-2024	03-31-2024	10-Q
2	02-22-2024	12-31-2023	10-K
3	11-07-2023	09-30-2023	10-Q
4	08-01-2023	06-30-2023	10-Q
5	05-15-2023	03-31-2023	10-Q
6	03-08-2023	12-31-2022	10-K
7	11-09-2022	09-30-2022	10-Q
8	08-09-2022	06-30-2022	10-Q
9	05-04-2022	03-31-2022	10-Q
10	03-01-2022	12-31-2021	10-K
11	11-08-2021	09-30-2021	10-Q
12	08-02-2021	06-30-2021	10-Q
13	05-12-2021	03-31-2021	10-Q
14	03-08-2021	12-31-2020	10-K
15	11-02-2020	09-30-2020	10-Q
16	08-03-2020	06-30-2020	10-Q
17	05-04-2020	03-31-2020	10-Q
18	03-09-2020	12-31-2019	10-K
19	11-04-2019	09-30-2019	10-Q
20	08-05-2019	06-30-2019	10-Q
21	05-06-2019	03-31-2019	10-Q
22	03-12-2019	12-31-2018	10-K
23	11-05-2018	09-30-2018	10-Q
24	08-02-2018	06-30-2018	10-Q
25	05-03-2018	03-31-2018	10-Q
26	03-12-2018	12-31-2017	10-K
27	11-06-2017	09-30-2017	10-Q
28	08-03-2017	06-30-2017	10-Q
29	05-04-2017	03-31-2017	10-Q
30	03-13-2017	12-31-2016	10-K
31	11-03-2016	09-30-2016	10-Q
32	08-04-2016	06-30-2016	10-Q
33	05-03-2016	03-31-2016	10-Q
34	03-14-2016	12-31-2015	10-K
35	11-05-2015	09-30-2015	10-Q
36	08-05-2015	06-30-2015	10-Q
37	05-07-2015	03-31-2015	10-Q
38	03-26-2015	12-31-2014	10-K
39	11-06-2014	09-30-2014	10-Q
40	08-07-2014	06-30-2014	10-Q

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Maintains Neutral on M...
05/02/2024 17:31:53

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and lowers the pri...

Minerva Neurosciences Q1 2024 GAAP EPS $(1...
05/01/2024 12:16:52

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(1.13) per share which beat the analyst consensus estimate of...

Minerva Neurosciences On April 10, Got Not...
04/12/2024 20:15:04

-SEC Filing

Dow Dips Over 100 Points; J.M. Smucker Pos...
02/27/2024 19:32:26

U.S. stocks traded mixed toward the end of trading, with the Dow Jones index falling more than 100 points on Tuesday. The Dow ...

why-helix-energy-solutions-shares-are-trading-lower-by-11-here-are-other-stocks-moving-in-tuesdays-mid-day-session

Why Helix Energy Solutions Shares Are Trad...
02/27/2024 18:18:56

Shares of Helix Energy Solutions Group, Inc. (NYSE: HLX) fell sharply during Tuesday’s session following weak earnings.

regulatory-setback-for-minerva-neurosciences-schizophrenia-treatment-candidate-fda-asks-for-more-data

Regulatory Setback For Minerva Neuroscienc...
02/27/2024 17:53:40

Minerva Neurosciences faces FDA challenges for roluperidone in schizophrenia treatment. Understand the clinical deficiencies an...

HC Wainwright & Co. Reiterates Neutral on ...
02/27/2024 17:35:33

HC Wainwright & Co. analyst Douglas Tsao reiterates Minerva Neurosciences (NASDAQ:NERV) with a Neutral and maintains $11...

12-health-care-stocks-moving-in-tuesdays-intraday-session

12 Health Care Stocks Moving In Tuesday's ...
02/27/2024 17:31:10

Crude Oil Gains 1%; Macy's Plans To Close ...
02/27/2024 17:24:14

U.S. stocks traded mixed midway through trading, with the Dow Jones index falling around 150 points on Tuesday. The Dow traded...

nasdaq-rises-50-points-lowes-earnings-top-views

Nasdaq Rises 50 Points; Lowe's Earnings To...
02/27/2024 14:42:28

U.S. stocks traded mixed this morning, with the Nasdaq Composite gaining around 50 points on Tuesday. Following the market ope...

Minerva Neurosciences Shares Resume Trade
02/27/2024 14:40:37

Minerva Neurosciences Shares Halted On Cir...
02/27/2024 14:36:42

Trading Halt: Halt status updated at 8:25:...
02/27/2024 13:25:06

Minerva Neurosciences Receives Complete Re...
02/27/2024 13:09:55

In the CRL, the FDA cited the following clinical deficiencies:Although one study (MIN-101C03) demonstrated statistical signific...

Trading Halt: Halted at 7:55:00 a.m. ET - ...
02/27/2024 12:55:04

Minerva Neurosciences: Q4 Earnings Insights
02/22/2024 13:20:14

Minerva Neurosciences Q4 EPS $(1.19) Misse...
02/22/2024 12:24:21

Minerva Neurosciences (NASDAQ:NERV) reported quarterly losses of $(1.19) per share which missed the analyst consensus estimate ...

12-health-care-stocks-moving-in-thursdays-intraday-session

12 Health Care Stocks Moving In Thursday's...
02/08/2024 17:31:40

12-health-care-stocks-moving-in-mondays-after-market-session

12 Health Care Stocks Moving In Monday's A...
02/05/2024 21:31:15

HC Wainwright & Co. Maintains Neutral on M...
08/02/2023 10:10:35

HC Wainwright & Co. analyst Douglas Tsao maintains Minerva Neurosciences (NASDAQ:NERV) with a Neutral and raises the pri...

Minerva Neurosciences Receives Refusal To ...
10/17/2022 12:33:01